The Sendai Virus Matrix Protein Appears to be Recruited in the Cytoplasm by the Viral Nucleocapsid to function in Viral Assembly and Budding Free

Abstract

The matrix (M) protein is viewed as the regulator of paramyxovirus particle assembly and budding. Accordingly it was observed to be mutated, and/or decreased in amount, in cases where virus particle production was significantly reduced. Here, a non-productive [non-defective and defective interfering (DI)] Sendai virus infection of COS cells is presented where virus particle production is abolished in the presence of a normal amount of intracellular M protein. In this infection the haemagglutinin—neuraminidase envelope glycoprotein is shown to be dispensable for virion production, and the fusion (F) envelope glycoprotein behaves as in a productive infection. The M protein is shown to accumulate in perinuclear patches within the cytoplasm. In contrast, localization in the plasma membrane is observed in productive infections. However in both productive and non-productive infections a significant fraction of M protein is found in association with cellular membranes. The M protein-membrane association is shown to take place in the absence of any other viral component, and the M protein-membrane complex exhibits properties similar to those observed for the integral membrane protein F. However these properties are distinct from those of the phosphoprotein, which is thought to associate with membranes in a non-specific manner. Concomitant with the cytoplasmic accumulation of M protein and the reduction of virus particle production in this non-productive infection, DI nucleocapsids are shown not to associate with cellular membrane fractions. This is a property which coincides with their poor envelopment in virus particles. Taken together, these data indicate the need for M protein to be recruited at the perinuclear membranes by the nucleocapsids to participate in viral assembly and budding. This view is consistent with a process of viral assembly taking place on internal cytoplasmic membranes rather than at the plasma membrane.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-5-1031
1994-05-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/5/JV0750051031.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-5-1031&mimeType=html&fmt=ahah

References

  1. Blumberg B., Giorgi C., Rose K, Kolakofsky D. 1985; Sequence determination of the Sendai virus fusion protein gene. Journal of General Virology 66:317–331
    [Google Scholar]
  2. Bordier C. 1981; Phase separation of integral membrane proteins in Triton-X114 solution. Journal of Biological Chemistry 256:1604–1607
    [Google Scholar]
  3. Calain P., Roux L. 1993; The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. Journal of Virology 67:4822–1830
    [Google Scholar]
  4. Calain P., Curran J., Kolakofsky D., Roux L. 1992; Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology 191:62–71
    [Google Scholar]
  5. Cattaneo R., Rose J. K. 1993; Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. Journal of Virology 67:1493–1502
    [Google Scholar]
  6. Cattaneo R., Schmid A., Rebmann G., Baczko K., Ter Meulen V., Bellini W. J., Rozenblatt S., Billeter M. A. 1986; Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology 154:97–107
    [Google Scholar]
  7. Cattaneo R., Rebmann G., Schmid A., Baczko K., Ter Meulen V., Billeter M. A. 1987; Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO Journal 6:681–688
    [Google Scholar]
  8. Curran J., Boeck R., Kolakofsky D. 1991; The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO Journal 10:3079–3085
    [Google Scholar]
  9. De Melo M., Mottet G., Örvell C., Roux L. 1992; Sendai virus M protein is found in two distinct isoforms defined by monoclonal antibodies. Virus Research 24:47–64
    [Google Scholar]
  10. Fuerst T. R., Niles E. G., Studier F. W., Moss B. 1986; Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proceedings of the National Academy of Sciences U.S.A: 838122–8126
    [Google Scholar]
  11. Haase A. T., Gantz D., Eble B., Walker D., Stowring L., Ventura P., Blum H., Wietgrefe S., Zupancic M., Tour-Telotte W., Gibbs C. J.Jr Norrby E., Rozenblatt S. 1985; Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. Proceedings of the National Academy of Sciences U.S.A: 823020–3024
    [Google Scholar]
  12. Hall W. W., Choppin P. W. 1979; Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology 99:443–147
    [Google Scholar]
  13. Johnson K. P., Norrby E., Swoveland P., Carrigan D. R. 1981; Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the central nervous system. Journal of Infectious Diseases 144:161–169
    [Google Scholar]
  14. Jones L. V., Compans R. W., Davis A. R., Bos T. J., Nayak D. P. 1985; Surface expression of influenza virus neuraminidase, an aminoterminally anchored viral membrane glycoprotein, in polarized epithelial cells. Molecular and Cellular Biology 5:2181–2189
    [Google Scholar]
  15. Kast W. M., Roux L., Curran J., Blom H. J. J., Voordouw A. C., Meloen R. H., Kolakofsky D., Melief C. J. M. 1991; Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proceedings of the National Academy of Sciences U.S.A: 882283–2287
    [Google Scholar]
  16. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  17. Morrison T., Portner A. 1991; Structure, function and intracellular processing of the glycoproteins of paramyxoviridae. In The Paramyxoviruses pp 347–382 Kingsbury D. W. Edited by New York & London: Plenum Press;
    [Google Scholar]
  18. Mottet G., Roux L. 1989; Budding efficiency of Sendai virus nucleocapsids: influence of size and ends of the RNA. Virus Research 14:175–188
    [Google Scholar]
  19. Mottet G., Portner A., Roux L. 1986; Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins. Journal of Virology 59:132–141
    [Google Scholar]
  20. Mottet G., Curran J., Roux L. 1990; Intracellular stability of nonreplicating paramyxovirus nucleocapsids. Virology 176:1–7
    [Google Scholar]
  21. Peeples M. E. 1991; Paramyxovirus M proteins: pulling it all together and taking it on the road. In The Paramyxoviruses pp 427–456 Kingsbury D. W. Edited by New York & London: Plenum Press;
    [Google Scholar]
  22. Portner A., Scroggs R. A., Marx P. A., Kingsbury D. W. 1975; A temperature-sensitive mutant of Sendai virus with an altered hemagglutinin-neuraminidase polypeptide: consequences for virus assembly and cytopathology. Virology 67:179–187
    [Google Scholar]
  23. Puddington L., Woodgett C., Rose J. K. 1987; Replacement of the cytoplasmic domain alters sorting of viral glycoprotein in polarized cells. Proceedings of the National Academy of Sciences U.S.A: 842756–2760
    [Google Scholar]
  24. Ray R., Roux L., Compans R. W. 1991; Intracellular targeting and assembly of paramyxovirus proteins. In The Paramyxoviruses pp 457–179 Kingsbury D. W. Edited by New York & London: Plenum Press;
    [Google Scholar]
  25. Rodriguez-Boulan E., Pendergast M. 1980; Polarized distribution of viral envelope proteins in the plasma membrane of infected epithelial cells. Cell 20:45–54
    [Google Scholar]
  26. Roth M. G., Compans R. W., Giusti L., Davis A. R., Nayak D. P., Gething M. -J., Sambrook J. 1983; Influenza hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell 33:435–443
    [Google Scholar]
  27. Roux L., Holland J. J. 1979; Role of defective interfering particles of Sendai virus in persistent infections. Virology 93:91–103
    [Google Scholar]
  28. Roux L., Waldvogel F. A. 1981; Establishment of Sendai virus persistent infection: biochemical analysis of the early phase of a standard plus defective interfering virus infection of BHK cells. Virology 112:400–410
    [Google Scholar]
  29. Roux L., Waldvogel F. A. 1982; Instability of the viral M protein in BHK-21 cells persistently infected with Sendai virus. Cell 28:293–302
    [Google Scholar]
  30. Roux L., Waldvogel F. A. 1983; Defective interfering particles of Sendai virus modulate HN expression at the surface of infected BHK cells. Virology 130:91–104
    [Google Scholar]
  31. Sanderson C. M., Mcqueen N. L., Nayak D. P. 1993; Sendai virus assembly: M protein binds to viral glycoproteins in transit through the secretory pathway. Journal of Virology 67:651–663
    [Google Scholar]
  32. Stephens E. B., Compans R. W., Earl P., Moss B. 1986; Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia virus vectors. EMBO Journal 5:237–245
    [Google Scholar]
  33. Stricker R., Roux L. 1991; The major glycoprotein of Sendai virus is dispensable for efficient virus particle budding. Journal of General Virology 72:1703–1707
    [Google Scholar]
  34. Tuffereau C., Roux L. 1988; Direct adverse effects of Sendai virus DI particles on virus budding and on M protein stability. Virology 162:417–426
    [Google Scholar]
  35. Tuffereau C., Lafay F., Flamand A. 1985a; Biochemical analysis of rabies virus proteins in three persistently infected BHK- 21 cell lines. Journal of General Virology 66:159–169
    [Google Scholar]
  36. Tuffereau C., Portner A., Roux L. 1985b; The role of haemagglutinin-neuraminidase glycoprotein cell surface expression in the survival of Sendai virus-infected BHK-21 cells. Journal of General Virology 66:2313–2318
    [Google Scholar]
  37. Vidal S., Mottet G., Kolakofsky D., Roux L. 1989; Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins. Journal of Virology 63:892–900
    [Google Scholar]
  38. Wechsler S. L., Rustigan R., Stallcup K. C., Byers K. B., Winston S. H., Fields B. N. 1979; Measles virus-specified polypeptide synthesis in two persistently infected HeLa cell lines. Journal of Virology 31:677–684
    [Google Scholar]
  39. Wild T. F., Bijlenga G. 1981; A rabies virus persistent infection in BHK-21 cells. Journal of General Virology 57:169–177
    [Google Scholar]
  40. Yoshida T., Nakayama Y., Nagura H., Toyoda T., Nishikawa K., Hamaguchi M., Nagai Y. 1986; Inhibition of the assembly of Newcastle disease virus by monensin. Virus Research 4:179–195
    [Google Scholar]
  41. Young K. Y. K., Heineke B. E., Wechsler S. L. 1985; M protein instability and lack of H protein processing associated with non productive persistent infection of HeLa cells by measles virus. Virology 143:536–545
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-5-1031
Loading
/content/journal/jgv/10.1099/0022-1317-75-5-1031
Loading

Data & Media loading...

Most cited Most Cited RSS feed